0001703057-24-000002.txt : 20240116 0001703057-24-000002.hdr.sgml : 20240116 20240116181423 ACCESSION NUMBER: 0001703057-24-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240114 FILED AS OF DATE: 20240116 DATE AS OF CHANGE: 20240116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hansen Carl L. G. CENTRAL INDEX KEY: 0001834412 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39781 FILM NUMBER: 24536318 MAIL ADDRESS: STREET 1: C/O ABCELLERA BIOLOGICS INC. STREET 2: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbCellera Biologics Inc. CENTRAL INDEX KEY: 0001703057 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 BUSINESS PHONE: (604) 559-9005 MAIL ADDRESS: STREET 1: 2215 YUKON STREET CITY: VANCOUVER STATE: A1 ZIP: V5Y 0A1 4 1 wk-form4_1705446854.xml FORM 4 X0508 4 2024-01-14 0 0001703057 AbCellera Biologics Inc. ABCL 0001834412 Hansen Carl L. G. C/O ABCELLERA BIOLOGICS INC 2215 YUKON STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA 1 1 1 0 Chief Executive Officer 0 Share option (right to buy) 5.39 2024-01-14 5 A 0 E 2095532 0 A 2034-01-14 Common Shares 2095532 8484723 D The shares subject to such option vest and become exercisable monthly in substantially equal installments over a four-year period, with the first tranche vested on January 14, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date. Tryn Stimart, attorney-in-fact 2024-01-16